PATRICK J ZENNER
CIK 1139036 · Exec. Chairman & Interim CEO · last filed 2026-01-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$208.1K
Companies
10
Total Filings
105
Lifetime Open-Market Net
-$2.09M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RNAC | Director | 12,974 | $9.51 | $123.4K | $0 | 4 | 2026-01-06 |
| Cartesian Therapeutics, Inc. (SELB) Delisted | Director | 55,248 | $0.88 | $48.7K | $0 | 8 | 2023-01-04 |
| WEST PHARMACEUTICAL SERVICES INC (WSTw) Delisted | Director | 39,974 | — | — | -$2.16M | 33 | 2022-04-01 |
| PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Director | — | — | — | $0 | 4 | 2012-01-09 |
| GERN | Director | 73,710 | $1.15 | $84.8K | $0 | 6 | 2010-05-21 |
| EXACT SCIENCES CORP (EXAS) Delisted | Exec. Chairman & Interim CEO | 124,994 | $104.91 | $13.11M | $0 | 5 | 2009-07-21 |
| CURAGEN CORP (CRGN) Delisted | Director | 10,000 | — | — | $27.5K | 5 | 2009-02-13 |
| SCIELE PHARMA, INC. (SCRX) Delisted | Director | 43,705 | — | — | $49.9K | 3 | 2008-04-28 |
| PRCS | Director | — | $27.74 | — | $0 | 1 | 2007-02-08 |
| DENDRITE INTERNATIONAL INC (DRTE) Delisted | Director | 19,000 | — | — | $0 | 1 | 2007-01-29 |
Recent Filings · Page 4 of 11
105 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-06-20 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-24 | — | Grant (A) | — | $0 | |
| 2017-05-03 | WEST PHARMACEUTICAL SERVICES INC (WSTw) Delisted | Grant (A) | +2,225 | $0 | EDGAR |
| 2016-12-14 | WEST PHARMACEUTICAL SERVICES INC (WSTw) Delisted | Gift (G) | −330 | $0 | EDGAR |
| 2016-12-09 | WEST PHARMACEUTICAL SERVICES INC (WSTw) Delisted | Buy (P) | +332 | $28.1K | EDGAR |
| 2016-05-25 | — | Grant (A) | — | $0 | |
| 2016-05-05 | WEST PHARMACEUTICAL SERVICES INC (WSTw) Delisted | Grant (A) | +2,966 | $0 | EDGAR |
| 2016-02-24 | WEST PHARMACEUTICAL SERVICES INC (WSTw) Delisted | Mixed | — | -$529.2K | EDGAR |
| 2015-12-14 | — | Buy (P) | +2,300 | $4.9K | |
| 2015-07-06 | WEST PHARMACEUTICAL SERVICES INC (WSTw) Delisted | Grant (A) | +714 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.